Your browser doesn't support javascript.
Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access Program.
Gustafson, M Sage; Patel, Aman; Hong, Chuan; Meline, Miles; Peña, Daniella; Tang, Charis; Fernandez Lynch, Holly.
  • Gustafson MS; Division of Medical Ethics, NYU Langone Health, New York, New York.
  • Patel A; University of Southern California, Los Angeles, California.
  • Hong C; Department of Population Health, NYU Langone Health, New York, New York.
  • Meline M; University of Pennsylvania, Philadelphia, Pennsylvania.
  • Peña D; Cornell University, Ithaca, New York.
  • Tang C; Rice University, Cupertino, California.
  • Fernandez Lynch H; Department of Medical Ethics and Health Policy Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
JAMA Netw Open ; 5(10): e2237540, 2022 10 03.
Article in English | MEDLINE | ID: covidwho-2074861
This cross-sectional study estimates the trial capacity of sites participating in the COVID-19 convalescent plasma expanded access program.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: JAMA Netw Open Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: JAMA Netw Open Year: 2022 Document Type: Article